Nikolas G. Kinney

ORCID: 0000-0003-1192-8149
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Advanced Neuroimaging Techniques and Applications
  • Neurological Disorders and Treatments
  • Stroke Rehabilitation and Recovery
  • Cell Adhesion Molecules Research
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Advanced Technologies in Various Fields
  • Spatial Neglect and Hemispheric Dysfunction
  • Advanced Technologies and Applied Computing
  • Neurological disorders and treatments
  • Advanced MRI Techniques and Applications
  • Cholinesterase and Neurodegenerative Diseases
  • Nuclear Receptors and Signaling
  • Botulinum Toxin and Related Neurological Disorders
  • Functional Brain Connectivity Studies
  • Neurobiology of Language and Bilingualism

University of Pennsylvania
2020-2022

Penn Center for AIDS Research
2021-2022

California University of Pennsylvania
2020

Nanotherapeutics (United States)
2017

Abstract Introduction The ATN framework provides an in vivo diagnosis of Alzheimer's disease (AD) using cerebrospinal fluid (CSF) biomarkers pathologic amyloid plaques (A), tangles (T), and neurodegeneration (N). is rarely evaluated pathologically confirmed patients its poor sensitivity to suspected non‐Alzheimer's pathophysiologies (SNAP), including frontotemporal lobar degeneration (FTLD), leads misdiagnoses. We compared accuracy (ATN TAU ) CSF total tau (t‐tau) a modified strategy NfL...

10.1002/alz.12233 article EN Alzheimer s & Dementia 2020-11-23

Hyperphosphorylation and aggregation of tau protein is a critical factor in many neurodegenerative diseases. These diseases are increasing prevalence, there currently no cures. Previous work from our group others has shown that tyrosine kinase inhibitors (TKIs) can stimulate autophagy, decrease pathological proteins, improve symptoms models neurodegeneration. Here we examined the role pazopanib mouse express either human mutant P301L (TauP301L) or triple amyloid precursor (3x-AβPP). The...

10.3233/jad-170429 article EN Journal of Alzheimer s Disease 2017-09-01

Background: An understudied variant of Alzheimer’s disease (AD), the behavioral/dysexecutive AD (bvAD), is associated with progressive personality, behavior, and/or executive dysfunction and frontal atrophy. Objective: This study characterizes neuropsychological neuroanatomical features bvAD by comparing it to behavioral frontotemporal dementia (bvFTD), amnestic (aAD), subjects normal cognition. Methods: Subjects included 16 bvAD, 67 bvFTD, 18 aAD patients, 26 healthy controls....

10.3233/jad-215728 article EN Journal of Alzheimer s Disease 2022-08-02

Behavioral variant frontotemporal degeneration (bvFTD) is clinically characterized by progressive decline in social and executive domains. Previous work suggests that early lifestyle factors such as education occupational attainment may relate to structural integrity moderate the rate of cognitive bvFTD, but role other cognitively stimulating activities understudied. We sought investigate effect on cortical thickness (CT) bvFTD. bvFTD patients (n = 31) completed a baseline MRI scan,...

10.1016/j.nicl.2021.102629 article EN cc-by-nc-nd NeuroImage Clinical 2021-01-01

Background: Previous research finds a range of numbers impairments in Parkinsonian syndromes (PS), but has largely focused on how visuospatial impact deficits basic numerical processes (e.g., magnitude judgments, chunking). Differentiation between these functions and more complex often utilized everyday tasks may help elucidate neurocognitive neuroanatomic bases PS. Objective: To test correlates processing PS, we assessed number abilities, neuropsychological performance, cortical thickness...

10.3233/jad-215327 article EN Journal of Alzheimer s Disease 2022-07-05

ABSTRACT An understudied non-amnestic variant of Alzheimer’s disease (AD), behavioral AD (bvAD) is associated with progressive personality, behavior, or executive dysfunction and frontal atrophy. This study characterizes the neuropsychological neuroanatomical features bvAD by comparing it to frontotemporal dementia (bvFTD), amnestic (aAD), subjects normal cognition. Subjects included 16 bvAD, 67 bvFTD, 18 aAD patients, 26 healthy controls. Compared showed more significant visuospatial...

10.1101/2022.01.04.21268578 preprint EN cc-by-nc medRxiv (Cold Spring Harbor Laboratory) 2022-01-05

ABSTRACT Behavioral variant frontotemporal degeneration (bvFTD) is clinically characterized by progressive decline in social and executive domains. Previous work suggests that early lifestyle factors such as education occupational attainment may relate to structural integrity moderate the rate of cognitive bvFTD, but role other cognitively stimulating activities understudied. We sought investigate effect on cortical thickness (CT) bvFTD. bvFTD patients (n=31) completed a baseline MRI scan,...

10.1101/2021.01.10.21249399 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2021-01-13

Abstract Background Recent models propose that spread of Alzheimer's disease (AD) pathology may be mediated by white matter connectivity. AD clinical variants exhibit partially distinct patterns gray atrophy. However, it is less clear whether phenotypic differences extend to patients' connectomes. We hypothesized connectivity would differ between healthy controls, amnestic (aAD), and non‐amnestic (naAD), including behavioral variant (bvAD), logopenic‐variant primary progressive aphasia...

10.1002/alz.054401 article EN Alzheimer s & Dementia 2021-12-01
Coming Soon ...